Jonathan Peskoff

Chief Executive Officer at

F3 Platform Biologics, Inc.

53 year

5 connections

Consumer Services

Finance

Health Technology

Profile

Jonathan E.
Peskoff is the founder of F3 Platform Biologics, Inc., founded in 2018, serving as Chief Executive Officer & Secretary since 2021.
Former job includes General Partner at NextPoint Partners.
Education includes undergraduate studies at the University of Southern California.

Jonathan Peskoff active positions

Companies	Position	Start
F3 Platform Biologics, Inc. F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics	Chief Executive Officer	2020-12-31

All active positions of Jonathan Peskoff

Former positions of Jonathan Peskoff

Companies	Position	End
NextPoint Partners NextPoint Partners Investment ManagersFinance NextPoint Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Private Equity Investor	2004-01-30

See the detail of Jonathan Peskoff's experience

Training of Jonathan Peskoff

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jonathan Peskoff's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
University of Southern California University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NextPoint Partners NextPoint Partners Investment ManagersFinance NextPoint Partners invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Finance
F3 Platform Biologics, Inc. F3 Platform Biologics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel therapeutics	Health Technology